Clinical Trial Update: Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications [Phase 2]

View source ↗

Summary

Phase 2 results for BGP345A in opioid-induced constipation show safety signals and preliminary efficacy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• BGP345A

Snippet

Sponsor: BioGaia Pharma AB | Conditions: Opioid-Induced Constipation | Phase 2 | Status: COMPLETED